Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Thyroid Neoplasms × Metformin × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 17 Insulin Resistance 5 Obesity 3 Neoplasms 3 Prostatic Neoplasms 2 Menstruation Disturbances 2 Breast Neoplasms 2 Weight Loss 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Prediabetic State 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-DM Stage II High-risk Colorectal Cancer 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Motor Activity 1 Metabolic Syndrome 1 Medulloblastoma 1 Infertility, Female 1 Infertility 1 Hyperandrogenism 1 Female 1 Endometrial Neoplasms 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Iodine-131 3 Thyrotropin Alfa 2 vandetanib 1 lenvatinib 1 fosbretabulin 1 combretastatin 1 cabozantinib 1 Thyroidectomy 1 Sorafenib 1 Ropivacaine 1 Radiotherapy 1 Paclitaxel 1 Neck Dissection 1 Metformin 1 Epinephrine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05468554 2022-10-19

METHYR

Medical University of Bialystok

Phase 3 Not yet recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡